Influenza Virus Host Response of C57Bl/6 Mice Treated with TACI-Ig

REFERENCES

• Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., Soppet D., Charters M., Gentz R., Parmelee D., Li Y., Galperina O., Giri J., Roschke V., Nardelli B., Carrell J., Sosnovtseva S., Greenfield W., Ruben S.M., Olsen H.S., Fikes J., Hilbert D.M. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999; 285: 260–263, [CSA]
   PubMed Web of Science ®Google Scholar
• Dillon S.R., Gross J.A., Ansell S.M., Novak A.J. An APRIL to remember: novel TNF ligands as therapeutic targets. Nature Reviews Drug Discovery 2006; 5: 235–246, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Stohl W. A therapeutic role for BLyS antagonists. Lupus 2004; 13: 317–322, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Koyama T., Tsukamoto H., Miyagi Y., Himeji D., Otsuka J., Miyagawa H., Harada M., Horiuchi T. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann. Rheum. Dis 2005; 64: 1065–1067, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Tan S.M., Xu D., Roschke V., Perry J.W., Arkfeld D.G., Ehresmann G.R., Migone T.S., Hilbert D.M., Stohl W. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum 2003; 48: 982–992, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cheema G.S., Roschke V., Hilbert D.M., Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 2001; 44: 1313–1319, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Novak A.J., Darce J.R., Arendt B.K., Harder B., Henderson K., Kindsvogel W., Gross J.A., Greipp P.R., Jelinek D.F. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 2004; 103: 689–694, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Moreaux J., Legouffe E., Jourdan E., Quittet P., Reme T., Lugagne C., Moine P., Rossi J.F., Klein B., Tarte K. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004; 103: 3148–3157, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C., Moore M., Littau A., Grossman A., Haugen H., Foley K., Blumberg H., Harrison K., Kindsvogel W., Clegg C.H. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000; 404: 995–999, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., Rixon M., Schou O., Foley K.P., Haugen H., McMillen S., Waggie K., Schreckhise R.W., Shoemaker K., Vu T., Moore M., Grossman A., Clegg C.H. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 2001; 15: 289–302, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Stein J.V., Lopez-Fraga M., Elustondo F.A., Carvalho-Pinto C.E., Rodriguez D., Gomez-Caro R., De Jong J., Martinez A.C., Medema J.P., Hahne M. APRIL modulates B and T cell immunity. J. Clin. Invest 2002; 109: 1587–1598, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Varfolomeev E., Kischkel F., Martin F., Seshasayee D., Wang H., Lawrence D., Olsson C., Tom L., Erickson S., French D., Schow P., Grewal I.S., Ashkenazi A. APRIL-deficient mice have normal immune system development. Mol. Cell. Biol 2004; 24: 997–1006, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Castigli E., Scott S., Dedeoglu F., Bryce P., Jabara H., Bhan A.K., Mizoguchi E., Geha R.S. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. USA 2004; 101: 3903–3908, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mackay F., Schneider P., Rennert P., Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol 2003; 21: 231–264, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Do R.K., Hatada E., Lee H., Tourigny M.R., Hilbert D., Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med 2000; 192: 953–964, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nardelli B., Belvedere O., Roschke V., Moore P.A., Olsen H.S., Migone T.S., Sosnovtseva S., Carrell J.A., Feng P., Giri J.G., Hilbert D.M. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001; 97: 198–204, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol 2002; 3: 822–829, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Baker K.P. BLyS–an essential survival factor for B cells: basic biology, links to pathology and therapeutic target. Autoimmun. Rev 2004; 3: 368–375, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Amanna I.J., Dingwall J.P., Hayes C.E. Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice. J. Immunol 2003; 170: 4593–4600, [CSA]
   PubMed Web of Science ®Google Scholar
• Avery D.T., Kalled S.L., Ellyard J.I., Ambrose C., Bixler S.A., Thien M., Brink R., Mackay F., Hodgkin P.D., Tangye S.G. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin. Invest 2003; 112: 286–297, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Owens S.L., Osebold J.W., Zee Y.C. Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus. Infect. Immun 1981; 33: 231–238, [CSA]
   PubMed Web of Science ®Google Scholar
• Gerhard W. The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol 2001; 260: 171–190, [CSA]
   PubMed Web of Science ®Google Scholar
• Burleson G.R. Pulmonary immunocompetence and pulmonary immunotoxicology. Experimental Immunotoxicology, R. Smialowicz, M.P. Holsapple. CRC Press, Inc., Boca Raton, Florida 1996; 113–135
   Google Scholar
• Burleson G.R. Influenza virus host resistance model for assessment of immunotoxicity, immunostimulation, and antiviral compounds. Methods in immunotoxicology, G.R. Burleson, J.H. Dean, A.E. Munson. Wiley-Liss, Inc., New York, N.Y. 1995; 181–202
   Google Scholar
• Lebrec H., Sarlo K., Burleson G.R. Effect of influenza virus infection on ovalbumin-specific IgE responses to inhaled antigen in the rat. J. Toxicol. Environ. Health 1996; 49: 619–630, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Burleson G.R. Models of respiratory immunotoxicology and host resistance. Immunopharmacology 2000; 48: 315–318, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Burleson G.R., Lebrec H., Yang Y.G., Ibanes J.D., Pennington K.N., Birnbaum L.S. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam. Appl. Toxicol 1996; 29: 40–47, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Lebrec H., Burleson G.R. Influenza virus host resistance models in mice and rats: utilization for immune function assessment and immunotoxicology. Toxicology 1994; 91: 179–188, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sedger L.M., Hou S., Osvath S.R., Glaccum M.B., Peschon J.J., van Rooijen N., Hyland L. Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha. J. Immunol 2002; 169: 6193–6201, [CSA]
   PubMed Web of Science ®Google Scholar
• Lohman B.L., Welsh R.M. Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice. J. Virol 1998; 72: 7815–7821, [CSA]
   PubMed Web of Science ®Google Scholar
• Ely K.H., Cauley L.S., Roberts A.D., Brennan J.W., Cookenham T., Woodland D.L. Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections. J. Immunol 2003; 170: 1423–1429, [CSA]
   PubMed Web of Science ®Google Scholar
• Woodland D.L., Hogan R.J., Zhong W. Cellular immunity and memory to respiratory virus infections. Immunol. Res 2001; 24: 53–67, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lebrec H., Roger R., Blot C., Burleson G.R., Bohuon C., Pallardy M. Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells. Toxicology 1995; 96: 147–156, [CSA]
   Google Scholar
• Topham D.J., Tripp R.A., Hamilton-Easton A.M., Sarawar S.R., Doherty P.C. Quantitative analysis of the influenza virus-specific CD4 + T cell memory in the absence of B cells and Ig. J. Immunol 1996; 157: 2947–2952, [CSA]
   PubMed Web of Science ®Google Scholar
• Harada Y., Muramatsu M., Shibata T., Honjo T., Kuroda K. Unmutated immunoglobulin M can protect mice from death by influenza virus infection. J. Exp. Med 2003; 197: 1779–1785, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar